Kiniksa Pharmaceuticals International PLC Sustainability Reports
A biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
Sector: Manufacturing
Country: United Kingdom
Exchange: Nasdaq
FIGI: BBG00KT2KGM7
1 reports from 2025 to 2025
